Article info
PDFResponse
In defence of a broad approach to public interest in health data research
- Correspondence to Dr G Owen Schaefer, Centre for Biomedical Ethics, National University of Singapore, Yong Loo Lin School of Medicine, Singapore 119077, Singapore; owen_schaefer{at}nus.edu.sg
Citation
In defence of a broad approach to public interest in health data research
Publication history
- Received September 7, 2020
- Revised October 14, 2020
- Accepted October 20, 2020
- First published December 10, 2020.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Public interest in health data research: laying out the conceptual groundwork
- The perils of a broad approach to public interest in health data research: a response to Ballantyne and Schaefer
- Consent and the ethical duty to participate in health data research
- Research or clinical care: what’s the difference?
- Taxonomy of justifications for consent waivers: When and why are public views relevant?
- Family history and adoption in the UK: conflicts of interest in medical disclosure
- Open government?
- Science, politics, ethics and the pandemic
- Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research
- How should we think about clinical data ownership?